Disulfiram for Cocaine-Alcohol Abuse - 3
NCT00000278 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2020-06-18
Summary
The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
Conditions
- Alcohol-Related Disorders
- Cocaine-Related Disorders
Interventions
- DRUG
-
Disulfiram
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
VA Connecticut Healthcare System
collaborator FED -
Yale University
lead OTHER
Principal Investigators
-
Thomas R Kosten, M.D. · VA Connecticut Healthcare System
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-09-30
- Primary Completion
- 1999-08-31
- Completion
- 1999-08-31
Countries
- United States
Study Locations
More Related Trials
-
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
NCT00913484 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Relationship Between Disulfiram and Cocaine Self-administration.
NCT00729300 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
NCT00142844 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacogenetics of Disulfiram for Cocaine
NCT00149630 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873 ·Status: COMPLETED ·Phase: PHASE1
-
Multisite Controlled Trial of Cocaine Vaccine
NCT00969878 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Learning-based Treatment of Cocaine Dependence With Medication
NCT01526538 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
NCT00567320 ·Status: COMPLETED ·Phase: NA
-
Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
NCT00585754 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
NCT00136825 ·Status: COMPLETED ·Phase: PHASE1
-
Mazindol for Cocaine Abuse - 2
NCT00000277 ·Status: COMPLETED ·Phase: PHASE2
-
Aripiprazole to Reduce Cocaine Relapse
NCT00276874 ·Status: COMPLETED ·Phase: PHASE1
-
Piracetam for Treatment of Cocaine Addiction - 3
NCT00000198 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
NCT02455479 ·Status: RECRUITING ·Phase: PHASE1
-
Interactions Between Intravenous Cocaine and Acetazolamide or Quinine
NCT01851473 ·Status: COMPLETED ·Phase: PHASE1
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Novel Pharmacotherapy for Dual Dependence
NCT00448825 ·Status: UNKNOWN ·Phase: PHASE3
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
n-Acetylcysteine and Cocaine
NCT02141620 ·Status: COMPLETED ·Phase: EARLY_PHASE1